Results 141 to 150 of about 678,599 (312)

3D Bioprinted Head and Neck Squamous Cell Carcinoma (HNSCC) Model Using Tunicate Derived Nanocellulose (NC) Bioink

Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
A 3D bioprinted HNSCC model for use in anti‐cancer drug testing is established in proof‐of‐concept. The innovative tunicate‐derived nanocellulose hydrogel proved to be a viable alternative to gelatin‐based hydrogel, offering improved bioprintability for HNSCC model establishment.
Alexya Azhakesan, Johann Kern, Ankit Mishra, Christine Selhuber‐Unkel, Annette Affolter, Paul Gatenholm, Nicole Rotter, Karen Bieback   +7 more
wiley   +1 more source

Anti-Vascular Endothelial Growth Factor Crunch Syndrome in Proliferative Diabetic Retinopathy. [PDF]

JCEM Case Rep
Li Z, Zhang Y.
europepmc   +1 more source

Vascular Endothelial Growth Factor (VEGF) Expression in Human Coronary Atherosclerotic Lesions

, 1998
Mayumi Inoue, Hiroshi Itoh, Makiko Ueda, Takahiko Naruko, Akiko Kojima, Ryushi Komatsu, Kentaro Doi, Yoshihiro Ogawa, Naohisa Tamura, Kazuhiko Takaya, Toshio Igaki, Jun K. Yamashita, Tae‐Hwa Chun, Ken Masatsugu, Anton E. Becker, Kazuwa Nakao   +15 more
openalex   +1 more source

p42/p44 MAP Kinase Module Plays a Key Role in the Transcriptional Regulation of the Vascular Endothelial Growth Factor Gene in Fibroblasts [PDF]

, 1998
Julie Milanini, Francesc Viñals, Jacques Pouysségur, Gilles Pagès   +3 more
openalex   +1 more source

“Therapies Through Gut:” Targeted Drug Delivery for Non‐Gastrointestinal Diseases by Oral Administration

Advanced Healthcare Materials, EarlyView.
Schematic illustration of the mechanism of targeted delivery of nanoparticles including 1) paracellular, 2) endolysosomal escape, 3) receptor mediated endocytosis, and 4) M cell mediated transport for non‐GI diseases by oral administration such as atherosclerosis, cancer, diabetes, and brain diseases. Abstract Oral drug delivery is a promising approach
Subarna Ray, Shehzahdi S. Moonshi, Hang Thu Ta   +2 more
wiley   +1 more source

Vascular endothelial growth factor immunoexpression in oral paracoccidioidomycosis. [PDF]

Med Oral Patol Oral Cir Bucal
Dias ES, Freitas LC, Miyazawa M, Nogueira DA, Oliveira CE, Pereira AA, Hanemann JA.   +6 more
europepmc   +1 more source

Vascular Endothelial Growth Factor Is the Major Angiogenic Factor in Omentum: Mechanism of the Omentum-Mediated Angiogenesis

, 1997
Qingxue Zhang, Christopher J. Magovern, Charles A. Mack, Kurt T. Budenbender, Wilson Ko, Todd K. Rosengart   +5 more
openalex   +1 more source

Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis [PDF]

, 1999
Nils Ole Schmidt, Manfred Westphal, Christian Hagel, S�leyman Erg�n, D. Stavrou, Eliot M. Rosen, Katrin Lamszus   +6 more
openalex   +1 more source

Bioengineering a Patient‐Derived Vascularized Lung Tumor‐on‐Chip Model to Decipher Immunomodulation by the Endothelium

Advanced Healthcare Materials, EarlyView.
Most in vitro cancer models lack cellular diversity, functional complexity, and clinical relevance. This work highlights the generation of an innovative dynamic tetraculture with autologous patient‐derived cells within a vascularized tumor‐on‐chip, as well as the recapitulation of endothelial anergy features induced by the tumor microenvironment ...
Christine Lansche, Ségolène Ladaigue, Giacomo Gropplero, Nicolas Zimmermann, Martin Nurmik, Irina Veith, Manh‐Louis Nguyen, Solenn Brosseau, Nicolas Poté, Pierre Mordant, Arnaud Roussel, Fathia Mami‐Chouaib, Fatima Mechta‐Grigoriou, Gérard Zalcman, Fabrice Soncin, Stéphanie Descroix, Maria Carla Parrini   +16 more
wiley   +1 more source

Visual fields after anti-vascular endothelial growth factor therapy for retinopathy of prematurity. [PDF]

PLoS One
Imai K, Obata S, Matsumoto R, Nishida A, Iwasa M, Kakinoki M, Sawada O, Saishin Y, Ohji M.   +8 more
europepmc   +1 more source